Fundz

Vor Bio Appoints Jean-Paul Kress as Chief Executive Officer

PUBLIC · VORJun 25, 2025

Position

Chairman

Company

Vor Bio

Jean-Paul Kress
CambridgeOtherBiotechnologyHealth CareTherapeutics

Description

Vor Bio has appointed Jean-Paul Kress, M.D., as the new Chief Executive Officer and Chairman of the Board, following the departure of Dr. Robert Ang. This leadership change is effective immediately, marking a pivotal shift as Vor Bio aims for expansion.

Quick answer

Vor Bio Appoints Jean-Paul Kress as Chief Executive Officer (June 25, 2025). Vor Bio is based in Cambridge, Massachusetts, United States.

Who is the new Chairman at Vor Bio?
Vor Bio named Jean-Paul Kress Chairman, announced June 25, 2025.
What did Vor Bio announce on June 25, 2025?
Vor Bio has appointed Jean-Paul Kress, M.D., as the new Chief Executive Officer and Chairman of the Board, following the departure of Dr. Robert Ang. This leadership change is effective immediately, marking a pivotal shift as Vor Bio aims for expansion.
What does Vor Bio do?
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases.
Where is Vor Bio based?
Vor Bio is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Q32 Bio (June 25, 2025), STORM Therapeutics (June 26, 2025), Ascidian Therapeutics (June 24, 2025) and Candel Therapeutics (June 23, 2025) also announced leadership changes within 45 days of Vor Bio.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Vor Bio, and when

A new leader at Vor Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Vor Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vor Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vor Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vor Bio

Location

Cambridge, Massachusetts, United States

About

Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vor Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sherell
Likely contact at this company
••••••••@••••••••

See Sherell's verified email →

Jeremy
Likely contact at this company
••••••••@••••••••

See Jeremy's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Vor Bio's next move

Learn about Strategic plan

Vor Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.